Cutter & Co Brokerage’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-95
Closed -$2K 240
2022
Q3
$2K Hold
95
﹤0.01% 226
2022
Q2
$5K Hold
95
﹤0.01% 229
2022
Q1
$13K Sell
95
-83
-47% -$12.1K ﹤0.01% 230
2021
Q4
$30K Hold
178
0.01% 272
2021
Q3
$89K Sell
178
-50
-22% -$23.2K 0.02% 286
2021
Q2
$114K Hold
228
0.03% 290
2021
Q1
$116K Hold
228
0.03% 276
2020
Q4
$109K Buy
228
+143
+168% +$46.9K 0.03% 256
2020
Q3
$24K Hold
85
0.01% 259
2020
Q2
$16K Buy
+85
New +$14.1K 0.01% 235
2020
Q1
Sell
-85
Closed -$15K 297
2019
Q4
$15K Hold
85
0.01% 249
2019
Q3
$13K Hold
85
﹤0.01% 297
2019
Q2
$10K Sell
85
-27
-24% -$4.28K ﹤0.01% 302
2019
Q1
$19K Sell
112
-13
-10% -$2.23K 0.01% 292
2018
Q4
$15K Buy
+125
New +$19.2K 0.01% 267
2018
Q3
Sell
-167
Closed -$110K 292
2018
Q2
$110K Hold
167
0.04% 230
2018
Q1
$170K Buy
+167
New +$140K 0.07% 227

Other funds holding AMPE

Cutter & Co Brokerage's AMPE Position: Q4 2022 in Review

Cutter & Co Brokerage sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 95 shares — an estimated $2K sold.

Cutter & Co Brokerage first reported a position in AMPE in Q1 2018 and held it in 17 quarters. The position peaked at $170K in Q1 2018. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Cutter & Co Brokerage reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Cutter & Co Brokerage sold 95 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $2K.
  • Cutter & Co Brokerage first reported a position in Ampio Pharmaceuticals Inc. in Q1 2018 and held it in 17 quarters.
  • Cutter & Co Brokerage's Ampio Pharmaceuticals Inc. position peaked at $170K in Q1 2018.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Cutter & Co Brokerage's 13F filing for Q4 2022, filed 3 Feb 2023.